ABSTRACT
INTRODUCTION
Traditional dental surgery management and procedures usually lead to irreversible loss of dentition and formation of typical alveolar ridge bone height and width defects. From the very beginning, however, dental surgeons attempted to fill the dental and jaw bone defects using various materials [1] . As late as in the 20 th century new inventions opened up new possibilities of replacing missing teeth using dental implants and treating jaw bone defects of various aetiology using biological materials [2] . Thanks to these new methods, bone loss can be reduced significantly. Materials suitable for filling in jaw bone defects are in high demand today, instigating research and the examination of factors promoting optimum bone healing and reconstruction [3] . The use of patients' own tissues is often limited or even impossible. Usually, only small quantities of bone tissue can be collected, particularly from the most common oral collection sites used in outpatient care practice. This is associated with additional strain and risk of intraoperative and postoperative complications, such as bleeding, infections, and chronic pain at the collection site [4] .
Therefore, new graft sources were sought in order to provide adequate quantities of implantation materials. Optimum quantities of bone replacement materials can be obtained from materials collected from donors of the same species (allografts), animals (xenografts) or synthetic materials [4, 5] .
An appropriate amount of bone replacement material may be provided by natural materials of animal origin, i.e. xenografts.
Bone grafts may be of bovine (e.g. Bio-Oss, Cerabone) or equine (e.g. Bio-Gen) origin. Due to the potential risk of transmission of zoonotic diseases, these materials must be sterile and deproteinated to reduce their significant immunogenic potential, as well as submitted to a multi-hour annealing process for denaturation and carbonization. A negative outcome of these processes consists in a reduction of the osteoinductive potential of materials, as bone morphogenetic proteins are removed along with the other proteins.
The aim of this study was to evaluate the healing of bone defects after the use of Bio-Gen Mix.
MATERIALS AND METHODS
The study group consisted of 42 patients treated at the Chair and Department of Oral Surgery Lublin Medical University Dental Clinical Centre in the years 2010-2013 for dentigeneous cysts, periapical lesions in teeth requiring root apex resection, or patients requiring post-extraction ridge augmentation procedures, as well as guided bone regeneration procedures before scheduled implantations of Bio-Gen Mix bone replacement xenografts.
Detailed patient interviews and medical histories were collected including diseases, addictions, allergies and hypersensitivities.
Extra-and intraoral clinical examinations were also performed to determine the treatment needs of individual patients, the overall health of their dentition and periodontium, as well as oral hygiene. In order to reduce the potential sources of infection prior to the scheduled surgery procedures, patients were recommended to undergo thorough sanitation of the oral cavity, including conservative, endodontic, periodontic and surgical treatment. Required radiodiagnostic images were acquired before the treatment in all patients. Extraoral dental x-rays and panoramic x-rays were performed as standard diagnostic procedures.
Clinical and radiological assessments of the procedures were performed in all patients immediately after the procedure, as well as 3, 6, and 12 months after the procedure.
RESULTS
The results of radiological and clinical assessments were summarized using a 3-grade scale for the assessment of intra-osseous defects for the purposes of regenerative surgery [6, 7] . The scale was as follows: ȇ S -clinical success, ȇ D -dubious result, dubious positive clinical outcome and/ or the presence of pathological clinical symptoms, ȇ F -failure and/or the presence of pathological clinical symptoms.
Bone defects classified as S should be considered healed, while those classified as D or F should be considered non-healed.
Not all cases could demonstrate a whole remodelling of the implant within the patient's native bone after 12 months; however, such cases were classified into the category S (success), despite the appropriate regeneration rate as no disturbing clinical symptoms were observed. The results are presented in Table 1 and Figures 1-6 . No differences were observed in the assessments of the healing process after 3 and 6 months of treatment.
DISCUSSION
According to Dominiak and Łysiak [8] , the first prerequisite for the management algorithm in intra-osseous defect repair is to determine the size of the defect. The literature provides the concept of a critical size defect, i.e. a defect that can not be spontaneously filled by normal bone tissue. Animal studies determined the critical dimension to be 5 mm [9, 10] . In clinical practice the diameters of bone defects after the enducleation of inflammatory cyst lesions are rarely smaller than 5 mm. In our studies the largest dimension (diameter) of all defects was always larger than 5 mm.
Many authors bring up the question of the choice of the material to replace the lost bone tissue. Established years ago as the old standard, autologous bone graft seems to remain the optimum solution despite the growing availability of materials characterized by continuously improved properties [11, 12, 13, 14, 15, 16] .
Today, the question of bone replacement materials of natural or synthetic origin is being raised in many studies.
Many authors, e.g. Kozakiewicz et al. [17] , Ray et al. [18] , Merkx et al. [19, 20] , Traini et al. [21] , Bashara et al. [22] , Jensen et al. [23] , Šponer et al. [24] , Cestari et al. [25] , report the possibility of using bone replacement materials of various types in diverse clinical settings.
When analyzing the choice of materials, some authors bring up the potential risks of transmission of infectious agents, particularly viruses such as HCV, HBV, and HIV, or prion proteins. The use of autogeneic bone appears to be a rational choice in many cases, as these risks are thus eliminated.
Our studies demonstrate that in the case of small bone deficits, the use of bone replacement materials, e.g. materials of bovine origin, such as Bio-Gen Mix, is sufficiently effective. The procedure leads to good outcomes, relatively fast bone 
